Dachaigh › Ependymoma
Sgrùdaidhean clionaigeach Ependymoma a’ fastadh anns na SA
Tha 15 sgrùdaidhean airson Ependymoma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
- California3 sgrùdaidhean
- Maryland4 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Sgìre Cholumbia3 sgrùdaidhean
- Texas3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Natural History Study of Patients With Neurofibromatosis Type 2
A’ fastadhSgrùdadh amharc
Aoisean 8 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00598351Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
A’ fastadhÌre 1
Aoisean 6 gu 21 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07061626Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
A’ fastadhÌre 2
Suas gu aois 19 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
A’ fastadhÌre 1
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07390539Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04374305PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06161519Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
A’ fastadh
12 Months – 39 Years · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05057702Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
A’ fastadhÌre 1/2
Aoisean 4 gu 39 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT05278208Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06193759ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
A’ fastadhÌre 1
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT04732065LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
A’ fastadhÌre 1
Suas gu aois 22 · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT03750513Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
A’ fastadhÌre 1
Aoisean 1 gu 26 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
A’ fastadhÌre 1
Aoisean 3 gu 25 · Gach gnè · Air ùrachadh 9 Faoi 2026 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Dùbh 2025 · NCT04541082Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.